Income Investing: Cast a Wider Net With These High-Yield Dividend Aristocrats -- Barron's
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)
Medtech Shouldn't Be Greatly Impacted by RFK Jr. at HHS, Wells Fargo Says
This Is What Whales Are Betting On Johnson & Johnson
CHMP Recommends Approval Of Janssen's Rybrevant (Amivantamab) And Lazcluze (Lazertinib) Combo For First-Line Treatment Of EGFR-Mutated Advanced NSCLC, Potentially Establishing New Standard Of Care Pending European Commission Approval
Least Shorted S&P 500 Stocks in October
Eli Lilly and Co (LLY.US) and Johnson & Johnson (JNJ.US) have successively sued American institutions for obstructing pharmaceutical discount plans.
Eli Lilly and Co has filed a lawsuit against the United States Health Resources and Services Administration, accusing them of unreasonably trying to block Eli Lilly's specific discounting scheme for drugs supplied under the government's 340B program.
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Express News | EMA's Chmp: Lazcluze (Lazertinib) Received a Positive Opinion
Johnson & Johnson Initiated at Outperform by Wolfe Research
Johnson & Johnson Analyst Ratings
The top institutions have disclosed their Q3 US stock hold positions! They are still heavily invested in technology stocks, but some signs are emerging.
Recently, the 13F reports of institutional investors in the US stock market have been released one after another, becoming an important channel for outsiders to understand the investment trends on Wall Street.
Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.
① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Vaccines Makers Close Lower on Reports RFK Jr May Head HHS
Wolfe Research Upgrades Johnson & Johnson(JNJ.US) to Buy Rating, Raises Target Price to $190
Express News | Johnson & Johnson - Nipocalimab Shows 77% Igg Reduction in Phase 2 Study
Express News | Nipocalimab Demonstrates Significant Clinical Improvement in Disease Activity and Igg Reduction in Phase 2 Sjögren's Disease Study